InfuSystem positioned for ‘successful year’
By HME News Staff
Updated 9:18 AM CDT, Mon May 12, 2025
ROCHESTER HILLS, Mich. - InfuSystem Holdings has reported net revenues of $34.7 million for the first quarter of 2025, a 9% increase compared to the same period last year. Of that, Patient Services net revenue was $20.8 million, a 12% increase, and Device Solutions was $13.9 million, a 4% increase. It reported net loss of $300,000 this year vs. $1.1 million last year. “I’m very pleased to report 2025 is off to an excellent start demonstrating solid growth,” said Richard Dilorio, outgoing CEO. “The positive momentum we experienced in 2024 continued into the first quarter of 2025, positioning us for a successful year ahead. Our net revenue for the first quarter was $34.7 million, an increase of 9% over the prior year. This achievement was primarily led by the strength of our core business in Oncology and device rentals, along with growing contributions from Wound Care.”
Other financial results:
- Gross profit was $19.2 million, an increase of 16% vs. prior year.
- Gross margin was 55.2%, an increase of 3.7% vs. prior year.
- Adjusted EBITDA non-GAAP was $6.3 million, an increase of 64% vs. prior year.
- Adjusted EBITDA non-GAAP margin increased 6.2% to 18.2% vs. 12.1% prior year.
- Net operating cash flow was up 372% to $1.8 million, as of March 31, 2025.
- Stock repurchases totaled approximately $3 million for the quarter.
- Company liquidity totaled $47.6 million, as of March 31, 2025.
Related: InfuSystem’s Dilorio to step down.
Comments